Efficacy of a herbal drug and Minoxidil 2% solution for treating Telogen effluvium infection

Authors

  • amir hosein Siadat
  • hamid Rashnoo
  • shahla Enshaieh
Abstract:

Background: Telogen effluvium is a self-limited, non-scarring disease that shows itself as a diffuse hair loss of the scalp that usually occurs 3 months after an acute illness. Theoretically, Minoxidil solution has been suggested as a treatment for this condition. In this study, we compared the efficacy of the minoxidil and an herbal drug containing urtica diocia, chamomilla, thymus vulgaris, equisetum avenues and foeniculum vulgare for treating telogen effluvium. Material and methods: This study was a double – blind prospective study. 24 patients with telogen effluvium were allocated randomly in two groups and were treated with minoxidil and the herbal drug. Data were analyzed statistically. Results: The mean duration of telogen effluvium in the minoxidil group was 17 weeks and in the herbal drug group was 7 weeks. This difference was statistically significant. Conclusion: From this study, it is condoled that this herbal drug is effective in telogen effluvium although more studies are recommended in this field.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Telogen effluvium.

The term telogen effluvium, first coined by Kligman in 1961, refers to the loss of club (telogen) hair in disease states of the follicle. Kligman's hypothesis was that whatever the cause of hair loss, the follicle tends to behave in a similar way, namely the premature termination of anagen. "The follicle is precipitated into catagen and transforms into a resting stage that mimics telogen." Ipso...

full text

Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study

Background: Chronic telogen effluvium (CTE) may be primary or secondary to various causes, including drug reaction, nutritional deficiency and female pattern hair loss (FPHL).  Oral minoxidil stimulates hair growth, and topical minoxidil is used in the treatment of FPHL and male androgenetic alopecia. minoxidil has not been used to treat CTE. This study aimed to assess the treatment of CTE with...

full text

The Postpartum Telogen Effluvium Fallacy.

INTRODUCTION Postpartum telogen effluvium (PPTE) is a commonly described entity, but few studies deal with the real incidence and pathogenesis of this claimed common disease. OBJECTIVE To analyze the objective data published and to define the real incidence of the so-called PPTE. METHOD A retrospective review of the published data was conducted. RESULTS No statistically significant data w...

full text

Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium due to Topical Minoxidil Treatment.

Topical minoxidil, the only approved treatment for female pattern hair loss (FPHL), has been associated with scalp allergic contact dermatitis (ACD). We report the case of 2 female patients who developed ACD from minoxidil solution with severe telogen effluvium and psoriasiform scalp dermatitis. Scalp dermoscopy was useful to identify the psoriasiform vascular pattern, whereas patch testing mad...

full text

Telogen Effluvium: Is There a Need for a New Classification?

and male alopecia [1–4] . The prerequisite for delivering appropriate patient care is an understanding of the pathologic dynamics of hair loss and a potential multitude of causal relationships. Once the diagnosis is certain, treatment appropriate for that diagnosis is likely to control the problem. Ultimately, the best way to alleviate the emotional distress related to hair loss is to effective...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 8  issue None

pages  55- 61

publication date 2006-11

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023